Nasdaq Stock Market LLC filed a notification on October 30, 2026, to remove Biofrontera Inc.'s warrants from listing and registration on the Nasdaq exchange under Section 12(b) of the Securities Exchange Act of 1934.

Key Highlights

  • Security affected: The class of securities subject to removal is described in the filing as "warrant."
  • Exchange action: Nasdaq Stock Market LLC certified it met all requirements to file the delisting notification, signed by Tara Petta, AVP.
  • Regulatory basis: The exchange relied on 17 CFR 240.12d2-2(b), indicating the exchange complied with its own rules to strike the securities from listing and/or withdraw registration.
  • Commission file number: The issuer's Commission File Number is listed as 001-40943.
  • Filing date: The notification was executed and dated October 30, 2026.

Nasdaq Moves to Delist Biofrontera Warrants Under Exchange Rules

According to the filing, Nasdaq Stock Market LLC submitted a Form 25 notification on behalf of Biofrontera Inc. (Commission File Number 001-40943), a company incorporated in Massachusetts and headquartered in Woburn. The filing covers the removal from listing and registration of the issuer's warrants, a class of securities distinct from the company's common shares.

The filing identifies 17 CFR 240.12d2-2(b) as the applicable rule provision, which governs exchange-initiated delisting actions. Under this provision, the exchange, not the issuer, is the certifying party. Nasdaq certified in the filing that it "has reasonable grounds to believe that it meets all of the requirements for filing the Form 25" and that the notification was signed by Tara Petta, listed as AVP. The filing further notes that the Form 25 and any attached notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable.

Biofrontera Inc. is a pharmaceutical company focused on dermatology, operating under Commission File Number 001-40943 on the Nasdaq Stock Market. The delisting action pertains specifically to the warrant class of securities and does not reference any other class of securities on the exchange. The filing does not include financial metrics, earnings data, or forward-looking statements from the company.

What Was Disclosed

Nasdaq Stock Market LLC notified the SEC on October 30, 2026, of the removal of Biofrontera Inc.'s warrants from listing and registration on the exchange, citing 17 CFR 240.12d2-2(b) as the governing rule provision.